These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
218 related items for PubMed ID: 1777947
1. Tumor necrosis factor (cachectin) in the biology of septic shock syndrome. Tracey KJ. Circ Shock; 1991 Oct; 35(2):123-8. PubMed ID: 1777947 [Abstract] [Full Text] [Related]
2. Tumor necrosis factor: an updated review of its biology. Tracey KJ, Cerami A. Crit Care Med; 1993 Oct; 21(10 Suppl):S415-22. PubMed ID: 8403979 [Abstract] [Full Text] [Related]
3. Tumour necrosis factor (cachectin) and other cytokines in septic shock: a review of the literature. Dofferhoff AS, Vellenga E, Limburg PC, van Zanten A, Mulder PO, Weits J. Neth J Med; 1991 Aug; 39(1-2):45-62. PubMed ID: 1961351 [Abstract] [Full Text] [Related]
4. Anti-lipopolysaccharide and anti-tumor necrosis factor/cachectin antibodies for the treatment of gram-negative bacteremia and septic shock. Calandra T, Baumgartner JD, Glauser MP. Prog Clin Biol Res; 1991 Aug; 367():141-59. PubMed ID: 1924424 [Abstract] [Full Text] [Related]
5. Effects of pentoxifylline on tumor necrosis factor production and survival during lethal E. coli sepsis vs. disseminated candidiasis with fungal septic shock. Lechner AJ, Rouben LR, Potthoff LH, Tredway TL, Matuschak GM. Circ Shock; 1993 Apr; 39(4):306-15. PubMed ID: 8485822 [Abstract] [Full Text] [Related]
6. Endotoxin, tumor necrosis factor, and related mediators: new approaches to shock. Beutler B. New Horiz; 1993 Feb; 1(1):3-12. PubMed ID: 7922391 [Abstract] [Full Text] [Related]
7. Treatment of septic shock with antibodies to tumour necrosis factor. Cohen J, Exley AR. Schweiz Med Wochenschr; 1993 Mar 20; 123(11):492-6. PubMed ID: 8475356 [Abstract] [Full Text] [Related]